A Phase 1 Multicenter Study of Three Escalating Doses of hMaxi-K Gene Transfer in Female Participants With Overactive Bladder Syndrome and Detrusor Overactivity.

Trial Profile

A Phase 1 Multicenter Study of Three Escalating Doses of hMaxi-K Gene Transfer in Female Participants With Overactive Bladder Syndrome and Detrusor Overactivity.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2012

At a glance

  • Drugs Maxi-K gene therapy; Maxi-K gene therapy
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Mar 2012 Actual patient number is 21 according to ClinicalTrials.gov.
    • 21 Mar 2012 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top